. 2024a).
 In the landmark ESCHAR trial, patients with C5-C6 disease randomized to HL&S and
compression as compared to compression alone were found to have no significant differences in ulcer healing time (89% for the compression group and 93% for the compression
plus surgery group at three years) but significantly lower rates of ulcer recurrence (56%
for the compression group and 31% for the compression plus surgery group at 4 years,